m6A-centered Crosstalk Information
Mechanism of Crosstalk between m6A Modification and Epigenetic Regulation
| Crosstalk ID |
M6ACROT00650
|
[1], [2], [3], [4] | |||
: m6A sites
Indirect
Enhancement
RNA modification
FOS
FOS
FTO
Demethylation
: modification sites
|
|||||
| m6A Modification: | |||||
|---|---|---|---|---|---|
| m6A Regulator | Methyltransferase-like 3 (METTL3) | WRITER | |||
| m6A Target | microRNA 221 (MIR221) | ||||
| Epigenetic Regulation that have Cross-talk with This m6A Modification: | |||||
| Epigenetic Regulation Type | RNA modification (RNAMod) >> N6,2'-O-dimethyladenosine (m6Am) | ||||
| Epigenetic Regulator | Fat mass and obesity-associated protein (FTO) | ERASER | View Details | ||
| Regulated Target | Protein c-Fos (FOS) | View Details | |||
| Crosstalk Relationship | m6A → m6Am | Enhancement | |||
| Crosstalk Mechanism | m6A modification indirectly impacts RNA modification through downstream signaling pathways | ||||
| Crosstalk Summary | METTL3 interacts with microRNA 221 (MIR221), decreasing its m6A level and promoting its physical interaction with Protein c-Fos (FOS), which was regulated by FTO-mediated m6Am modification. | ||||
In-vitro Model |
COV434 | Ovarian small cell carcinoma, hypercalcemic type | Homo sapiens | CVCL_2010 | |
| KGN | Ovarian granulosa cell tumor | Homo sapiens | CVCL_0375 | ||
| T24 | Bladder carcinoma | Homo sapiens | CVCL_0554 | ||
| Ej138 | Bladder carcinoma | Homo sapiens | CVCL_2443 | ||
| MCF-7 | Invasive breast carcinoma | Homo sapiens | CVCL_0031 | ||
Full List of Potential Compound(s) Related to This m6A-centered Crosstalk
| Protein c-Fos (FOS) | 1 Compound(s) Regulating the Target | Click to Show/Hide the Full List | ||
| ISIS 10639 | Investigative | [5] | ||
| External Link | ||||
References
: m6A sites
: modification sites